The activation of the
death receptors,
tumor necrosis factor-receptor-1 (TNF-R1) or CD95, is a hallmark of inflammatory or viral
liver disease. In different murine in vivo models, we found that livers depleted of gamma-glutamyl-
cysteinyl-glycine (GSH) by endogenous enzymatic conjugation after
phorone treatment were resistant against
death receptor-elicited injury as assessed by
transaminase release and histopathology. In apoptotic models initiated by engagement of CD95, or by injection of TNF or
lipopolysaccharide into
galactosamine-sensitized mice, hepatic caspase-3-like
proteases were not activated in the GSH-depleted state. Under GSH depletion, also
caspase-independent, TNF-R1-mediated injury (high-dose
actinomycin D or
alpha-amanitin), as well as necrotic hepatotoxicity (high-dose
lipopolysaccharide) were entirely blocked. In the T-cell-dependent model of
concanavalin A-induced hepatotoxicity, GSH depletion resulted in a suppression of
interferon-gamma release, delay of systemic TNF release, hepatic
nuclear factor-kappaB activation, and an abrogation of sinusoidal endothelial cell detachment as assessed by electron microscopy. When GSH depletion was initiated 3 hours after
concanavalin A injection, ie, after the peak of early pro-inflammatory
cytokines, livers were still protected. We conclude that sufficient hepatic GSH levels are a prerequisite for the execution of
death receptor-mediated hepatocyte demise.